Health and Fitness Health and Fitness
Mon, January 30, 2012
Sat, January 28, 2012
Fri, January 27, 2012
Thu, January 26, 2012
Wed, January 25, 2012
Tue, January 24, 2012
[ Tue, Jan 24th 2012 ] - Market Wire
Quarterly Report I 11/12
[ Tue, Jan 24th 2012 ] - Market Wire
Codexis Announces CFO Departure
Mon, January 23, 2012
Sun, January 22, 2012
Sat, January 21, 2012
Fri, January 20, 2012
[ Fri, Jan 20th 2012 ] - Market Wire
00 A.M. ET
Thu, January 19, 2012
Wed, January 18, 2012
[ Wed, Jan 18th 2012 ] - Market Wire
30 p.m. CST

Codexis Announces CFO Departure


//health-fitness.news-articles.net/content/2012/01/24/codexis-announces-cfo-departure.html
Published in Health and Fitness on Tuesday, January 24th 2012 at 13:18 GMT by Market Wire   Print publication without navigation


Codexis Announces CFO Departure -- REDWOOD CITY, Calif., Jan. 24, 2012 /PRNewswire/ --

Codexis Announces CFO Departure

[ ]

REDWOOD CITY, Calif., Jan. 24, 2012 /PRNewswire/ -- Codexis, Inc. (Nasdaq: [ CDXS ]) today announced that the Company's Chief Financial Officer, Robert Lawson, has advised the Company of his decision to resign as Chief Financial Officer in order to accept a position at a private software company.  The Board of Directors will conduct an immediate search for a new CFO.

"We thank Bob for his contributions to Codexis," said Alan Shaw, Ph. D, President and Chief Executive Officer. "We are grateful for his leadership, and we all wish Bob the best as he returns to the software industry."

In order to facilitate an orderly transition, Mr. Lawson will remain with the Company as Chief Financial Officer to oversee the year-end accounting close and annual audit process, and the filing of the Company's Annual Report on Form 10-K.  Mr. Lawson will discuss Codexis' fourth quarter and full year 2011 financial results on its fiscal 2011 earnings conference call on February 7, 2012.

About Codexis
Codexis is an industrial biotechnology company developing high value sustainable chemicals, clean fuels, cost effective pharmaceutical processes and renewable bioindustrial ingredients to make industry more efficient, productive and profitable.  Partners and customers include global leaders such as Shell, Merck and Pfizer.  For more information, see [ www.codexis.com ].

Contacts: 
Media:  Wes Bolsen, [ wes.bolsen@codexis.com ], 650.421.8100
Investors:  Jay Sarwar, [ ir@codexis.com ], 650.421.8126

SOURCE Codexis, Inc.

[ Back to top ]

RELATED LINKS
[ http://www.codexis.com ]


Publication Contributing Sources